- Aug 5, 2019
- 1,852
- Tinnitus Since
- 05/2019
- Cause of Tinnitus
- Autoimmune hyperacusis from Sjogren's Syndrome
Some users are painting that kind of a picture. Most people are just interested in diagnostics and figuring out more nuances of the drug in vivo (i.e. is there any IHC regrowth, etc.). There is some cautious optimism that trial 113 (Severe) will give us more information.Am I right in witnessing that the general sentiment is back to being more positive about FX-322?
But before, earlier this year, when the initial study results on repeat dosing were published, everyone was completely devastated...?
But no, the roller coaster ride is not here -- it's a strawman. Most people have hope diversification (in SPI-1005, OTO-313, OTO-413, PIPE-505, PIPE-307, XEN496, etc.) and just hope that FX-322 provides benefit to hearing research.